Whitehawk Therapeutics, Inc. company logo
Whitehawk Therapeutics, Inc. logo

Whitehawk Therapeutics, Inc. (AADI) EV

Enterprise Value

N/A

Chart

SUGGESTED SERIES

Performance

AADI Performance
MetricDateValue1D1M3MYTD1Y3Y5Y
Enterprise Value-–––––––
-–––––––
PE Ratio-–––––––
TTM Revenue$27.78M+6.9%–+6.9%–+16.5%+739.9%–
TTM EPS$0.16+106.8%–+106.8%–+106.3%+101.5%+206.2%
Market Cap-–––––––
Quarterly Total Debt$0.00-100.0%–-100.0%–-100.0%-100.0%0.0%
Quarterly Cash & Cash Equivalents$227.57M+693.8%–+693.8%–+323.1%+75.3%–
EV/EBITDA-–––––––

Highs

AADI Enterprise Value Highs Comparison
PeriodHighDateCurrent
1MN/AN/AN/A
3MN/AN/AN/A
6MN/AN/AN/A
1YN/AN/AN/A
3Y$65.25MN/A
5Y$379.35MN/A
All$452.59MN/A

Lows

AADI Enterprise Value Lows Comparison
PeriodLowDateCurrent
1MN/AN/AN/A
3MN/AN/AN/A
6MN/AN/AN/A
1YN/AN/AN/A
3Y-$191.83MN/A
5Y-$191.83MN/A
All-$191.83MN/A

History

DateValueChange
$49.93M+515.3%
-$12.02M-104.4%
DateValueChange
$276.14M-22.5%
$356.22M-

Formula

Enterprise Value = + −

Data Sources & References

  1. AADI Official Website aadibio.com
  2. AADI Profile on Yahoo Finance finance.yahoo.com/quote/AADI
  3. AADI Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/aadi